Atara Biotherapeutics (STU:AT2) Change In Receivables : €-32.50 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Atara Biotherapeutics Change In Receivables?

Atara Biotherapeutics's change in receivables for the quarter that ended in Mar. 2024 was €-1.59 Mil. It means Atara Biotherapeutics's Accounts Receivable increased by €1.59 Mil from Dec. 2023 to Mar. 2024 .

Atara Biotherapeutics's change in receivables for the fiscal year that ended in Dec. 2023 was €5.61 Mil. It means Atara Biotherapeutics's Accounts Receivable declined by €5.61 Mil from Dec. 2022 to Dec. 2023 .

Atara Biotherapeutics's Accounts Receivable for the quarter that ended in Mar. 2024 was €32.97 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Atara Biotherapeutics's Days Sales Outstanding for the three months ended in Mar. 2024 was 119.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Atara Biotherapeutics's liquidation value for the three months ended in Mar. 2024 was €-167.83 Mil.

Atara Biotherapeutics Change In Receivables Historical Data

The historical data trend for Atara Biotherapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Change In Receivables Chart

Atara Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-1.03

0.23

-37.04

5.61

Atara Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															37.20	-0.10	0.32	-31.13	-1.59

Atara Biotherapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-32.50 Mil.

Atara Biotherapeutics (STU:AT2) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Atara Biotherapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	32.967	/	25.168	*	91
=	119.53

2. In Ben Graham's calculation of liquidation value, Atara Biotherapeutics's accounts receivable are only considered to be worth 75% of book value:

Atara Biotherapeutics's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	42.54	-	242.494	+	0.75 * 32.967	+	0.5 * 14.797
=	-167.83

Atara Biotherapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics (STU:AT2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (STU:AT2) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT2:Germany

Address

2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (STU:AT2) Headlines

No Headlines